CD8A and lung cancer: Interestingly, Isomoto et al. recently reported that a fraction of EGFR mutant lung cancers sampled before and at TKI-treatment failure (progression) exhibited increased PD-L1 expression and that these tumors maintained higher CD8+ T-cell content58.